If you or a loved one is living with diabetes and struggling with a wound on your foot that simply will not heal, there may be a hidden culprit at work: biofilm. This microscopic menace is increasingly recognized as one of the most significant barriers to diabetic foot wound healing — yet many patients have never heard of it. At The Mayer Institute, we stay at the forefront of the latest research so we can offer the most effective, evidence-based care available.
What Is Biofilm — and Why Does It Matter?
Biofilm is a structured community of bacteria that attaches to a wound surface and surrounds itself with a protective, slimy coating called an extracellular matrix. Think of it as a fortress wall the bacteria build around themselves — shielding them from your immune system, from antiseptics, and from antibiotics. Once established, biofilm makes infections dramatically harder to treat.
Research published in recent years has revealed just how prevalent biofilm is in diabetic foot ulcers (DFUs). Studies show that biofilm formation is detected in over 60% of diabetic foot ulcer wound isolates, making it a near-universal feature of chronic, non-healing wounds. A 2024 systematic review in Frontiers in Clinical Diabetes and Healthcare confirmed that biofilm is not just common — it is a central driver of wound chronicity, antibiotic resistance, and treatment failure in diabetic foot infections.
The Scale of the Problem
Diabetic foot ulcers are already one of the most serious complications of diabetes. Approximately 18.6 million people worldwide are affected by a diabetic foot ulcer each year, and the lifetime risk of developing one if you have diabetes is estimated at 19 to 34%. Perhaps more sobering: once a wound develops, recurrence rates reach 65% within three to five years, and the five-year mortality rate for people with diabetic foot ulcers rivals many cancers — approaching 50 to 70% in complicated cases.
Biofilm is not the only reason wounds fail to heal — reduced blood flow, nerve damage (neuropathy), elevated blood sugar, and impaired immune response all play a role. But biofilm is increasingly understood to be the reason why wounds that receive otherwise appropriate treatment still stall. When bacteria are operating inside a biofilm, conventional systemic antibiotics may require concentrations 100 to 1,000 times higher than usual to be effective — concentrations that cannot be safely achieved in the body.
How Biofilm Is Addressed: Debridement as the Foundation
The most established and evidence-based method for disrupting biofilm in diabetic foot wounds is wound debridement — the removal of dead, infected, or non-healing tissue from the wound bed. The 2023 International Working Group on the Diabetic Foot (IWGDF) guidelines, widely considered the gold standard for diabetic foot care, confirm that sharp debridement by a trained clinician remains the primary recommendation for managing DFUs.
Sharp debridement physically disrupts and removes biofilm-laden tissue, reducing the bacterial burden and stimulating the wound edges to resume healing. The frequency of debridement should be determined by clinical judgment — some wounds require it weekly, others more or less often depending on the rate of biofilm reformation and tissue response. Importantly, the IWGDF guidelines emphasize that no other form of debridement — enzymatic, autolytic, ultrasonic, or laser-based — has been shown to be superior to sharp debridement as a standalone treatment. These adjunct approaches may play a role in specific situations but should not replace the core intervention.
Emerging Strategies: Beyond the Scalpel
Because biofilm continues to re-establish itself between debridement sessions, researchers are actively investigating adjunctive therapies to keep biofilm under control and promote healing:
- Super-oxidized solutions (SOS): These reactive oxygen species-based wound irrigants are showing promise as a non-antibiotic option for disrupting biofilm integrity and enhancing bacterial eradication. A 2025 review in Cardiovascular Diabetology highlighted SOS as particularly relevant in elderly patients with DFUs, where antibiotic resistance is especially concerning.
- Bacteriophage therapy: “Phage therapy” — using viruses that selectively target and destroy specific bacteria — is an emerging frontier for biofilm-infected wounds that have failed conventional treatment. While still largely experimental, 3D wound models mimicking the diabetic foot environment are being developed to accelerate research in this area.
- Multi-combinatorial approaches: Rather than relying on any single intervention, current evidence increasingly supports combining debridement with adjunctive topical agents, advanced wound dressings, and systemic therapies tailored to the wound’s microbial profile. This strategy is especially important given the rise of multidrug-resistant organisms in diabetic foot infections.
The 2023 IWGDF guidelines also conditionally support the use of sucrose octasulfate dressings, negative pressure wound therapy (for post-operative wounds), placental-derived products, and hyperbaric oxygen therapy as adjuncts when best standard care alone has not achieved wound closure.
What This Means for Your Care
If you have a diabetic foot wound that has been present for more than two to four weeks without meaningful improvement, biofilm is a likely contributor. This is not a reason for despair — it is a reason to seek specialized care from a team with the expertise, tools, and up-to-date knowledge to address it properly.
At The Mayer Institute, our approach to diabetic foot wounds is grounded in the latest evidence. We perform expert wound assessment and debridement, guide antibiotic therapy based on culture results, and draw on a full spectrum of advanced wound care modalities — from offloading and vascular assessment to advanced dressings and specialist referral when needed. Early, expert intervention is the single most important step toward avoiding serious complications like deep infection, osteomyelitis, or amputation.
Take Action Today
Don’t let a non-healing wound go unaddressed. Whether you are managing a new foot wound or dealing with one that has persisted for weeks or months, our team is here to help. Contact The Mayer Institute today to schedule a comprehensive diabetic foot assessment. The sooner biofilm and other barriers to healing are identified and treated, the better your chances of a full recovery — and of keeping your foot healthy for the long term.
The Mayer Institute specializes in the prevention and treatment of diabetic foot complications. Our clinic serves patients across the Hamilton and surrounding regions. Call us or use our online booking to arrange your appointment.
Comments
